HGC019

HGC019
Vaccine description
TargetSARS-CoV-2
Vaccine typemRNA
Clinical data
Other namesHGCO19, Gemcovac, GEMCOVAC-19
Routes of
administration
Intramuscular
ATC code
  • None

HGC019 is a mRNA and Self-amplifying mRNA (saRNA) based COVID-19 vaccine candidate being developed by Gennova Biopharmaceuticals and HDT Bio Corp. with active support from NIH under The Indo-US Vaccine Action Program (VAP) and Department of Biotechnology, India.[1]

  1. ^ "mRNA Vaccines – HGC019". Gennova Biopharmaceuticals Limited. Retrieved 13 January 2021.